T.Man Pharmaceutical Management
Management criteria checks 4/4
T.Man Pharmaceutical's CEO is Prapon Thanachotipan, appointed in Jul 2022, has a tenure of 4.17 years. directly owns 8.39% of the company’s shares, worth THB352.51M. The average tenure of the management team and the board of directors is 4.2 years and 4.1 years respectively.
Key information
Prapon Thanachotipan
Chief executive officer
฿55.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.2yrs |
| CEO ownership | 8.4% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO
Prapon Thanachotipan (44 yo)
Mr. Prapon Thanachotipan is Director since March 6, 2007 and CEO of T.Man Pharmaceutical Public Company Limited since July 7, 2022.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Acting Chief Sales Officer | 4.2yrs | ฿55.00k | 8.39% THB 352.5m | |
| Deputy CEO of Financial | no data | ฿75.00k | 3.55% THB 148.9m | |
| Deputy CEO of International Sales and Director | no data | ฿35.00k | 3.51% THB 147.4m | |
| Deputy Chief Executive Officer of Research & Development and Director | no data | ฿35.00k | 3.38% THB 141.9m | |
| CFO & Company Secretary | 3.7yrs | no data | no data | |
| COO & Head of Investor Relation | 4.2yrs | no data | no data | |
| Compliance Officer | no data | no data | no data | |
| Head of Internal Audit | no data | no data | no data | |
| Chief Procurement Officer | 4.2yrs | no data | no data | |
| Chief Engineering Officer | 4.2yrs | no data | no data |
Experienced Management: TMAN's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Acting Chief Sales Officer | 19.5yrs | ฿55.00k | 8.39% THB 352.5m | |
| Deputy CEO of Financial | 19.5yrs | ฿75.00k | 3.55% THB 148.9m | |
| Deputy CEO of International Sales and Director | 4.1yrs | ฿35.00k | 3.51% THB 147.4m | |
| Deputy Chief Executive Officer of Research & Development and Director | 4.1yrs | ฿35.00k | 3.38% THB 141.9m | |
| Independent Chairman | 3.8yrs | ฿937.20k | no data | |
| Independent Director | 3.8yrs | ฿702.60k | no data | |
| Independent Director | 3.8yrs | ฿681.16k | 0.050% THB 2.1m | |
| Director | 19.5yrs | ฿35.00k | 3.36% THB 141.0m | |
| Independent Director | less than a year | no data | no data |
Experienced Board: TMAN's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/10 12:56 |
| End of Day Share Price | 2026/09/10 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
T.Man Pharmaceutical Public Company Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Theethanat Jindarat | Yuanta Securities (Thailand) Company Limited |
| Kritawit Ratanakhanokchai | Yuanta Securities (Thailand) Company Limited |
| Athitaya Chinakanjanadit | Yuanta Securities (Thailand) Company Limited |